Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Olinger Margaret Create: Alert

All | News | Filings
Date FiledTypeDescription
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2023 4 Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.
Txns: Gifted 1,580 shares @ $0
03/20/2023 4 Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.
Txns: Granted 18,333 shares @ $0
Granted 82,500 options to buy @ $32.08, valued at $2.6M
01/10/2023 4 Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.
Txns: Sold 1,660 shares @ $36.0789, valued at $59.9k
Sold 743 shares @ $36.7888, valued at $27.3k
01/10/2022 4 Olinger Margaret (Chief Commercial Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.
Txns: Granted 28,333 shares @ $0
Bought 6,842 shares @ $19, valued at $130k
Granted 127,500 options to buy @ $19, valued at $2.4M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy